Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.43 USD | +0.31% | -1.67% | +38.81% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.81% | 2.17B | |
+51.85% | 55.07B | |
-1.51% | 41.79B | |
+45.15% | 40.22B | |
-7.59% | 28.17B | |
+12.29% | 26.28B | |
-21.19% | 18.93B | |
+7.32% | 13.03B | |
+29.89% | 12.26B | |
+26.47% | 12.21B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- B. Riley Boosts Price Target on Kymera Therapeutics to $37 From $35, Reiterates Neutral Rating